Discover Transpara through RSNA 2026 scientific sessions
By ScreenPoint Insights on November 02, 2026
RSNA 2026 is the forum for world-class research on innovation and explorations of real-world applications across emerging technology. In 2026, Transpara will be a topic of intense focus across the agenda, with presentations and posters across the entire conference.
Featured session: outside of the main scientific programming, ScreenPoint Medical's own Andreas Lauritzen will be hosting a session on Image-Based Risk: The Next Frontier in Breast Cancer Screening on Wednesday, December 2nd at 10:30 AM in the AI Showcase Theater. Join us to discover how new models can use a woman's existing mammogram to predict her risk of developing breast cancer in the future.
Additional sessions and posters featuring Transpara Breast AI are featured below:
Sunday, November 29
S2-SSBR01. Breast Imaging (Breast Cancer Screening: Policy Updates, Equity, and Operational Challenges)
Prospective trial of AI-supported screening at a cancer center
Speaker: Sarah Eskreis-Winkler | When: 10:30 AM | Where: S404
Prospective AI evaluation in a population screening program
Speaker: Charlotte J Yong-Hong | When: 10:30 AM | Where: S405
Monday, November 30
M3-SSBR03. Breast Imaging (AI-based breast cancer risk prediction: from deep learning to clinical decision support)
Regulatory - Approved Deep Learning Systems for Breast Cancer Screening: A Systematic Review and Meta-Analysis of Real-World Diagnostic Performance
Speaker: Yu-Cuan Chen | When: 9:30 AM | Where: S406A
M3-SSBR04. Breast Imaging (Supplemental Screening in Dense and High-Risk Breasts: Evidence, AI-Guided Triage, and Clinical Trials)
Performance and calibration of two AI risk models in Europe
Speaker: Yu-Kuan Wang | When: 9:30 AM | Where: S402
M5B-SPBR. Breast Imaging Monday Afternoon Posters Discussions II
AI and inter-reader variability in community screening
Speaker: Kara L. Carlson | When: 12:45 PM | Where: Poster Discussions
Tuesday, December 1
T3-SSBR05. Breast Imaging (AI for breast cancer detection: Performance, Validation, and Radiologist Impact)
Improving efficiency of breast screening with AI: Autonomous reading of low-suspicion mammograms and supplemental imaging selection
Speaker: Joshua Rothwell | When: 9:30 AM | Where: S406A
Large-scale US evaluation of four FDA-cleared AI tools for breast cancer detection on screening mammography
Speaker: Ojas Anjurbhai Ramwala | When: 9:30 AM | Where: S406A
Comparing the performance of top ranked AI models from the RSNA 2023 screening mammography breast cancer detection AI challenge to commercial AI models
Speaker: Yan Chen | When: 9:30 AM | Where: S406A
T7-SSBR06. Breast Imaging (Axillary Staging, Nuclear Medicince and Surgical Planning)
Impact of prior breast surgery and biopsy clips on the real-world performance of an FDA-approved AI tool for screening mammography
Speaker: Emily Abinder | When: 3:00 PM | Where: N227B
Thursday, December 3
R1-SSBR10. Breast Imaging (Risk Model Validation, Breast Density Quantififcation, and Cross-Population Generalisability)
Artificial Intelligence-based mammography breast density estimation: a crossvendor comparison of deep learning algorithms with Volpara for mammographic breast density estimation
Speaker: Joshua Rothwell | When: 8:00 AM | Where: S406A
R4-STCE1. Science Session (Cancer Screening with Imaging in the Era of Precision Medicine)
When AI Evolves: Clinical Implications of algorithm and threshold changes in screening mammography
Speaker: Shefali Jain | When: 11:00 AM | Where: Learning Center Theater
See you in Chicago shortly!
.webp?width=217&height=60&name=Screenpoint-Med%20(1).webp)